Literature DB >> 32580066

Virtual scribing within otolaryngology during the COVID-19 pandemic and beyond.

Renee Noordzij1, Michal J Plocienniczak2, Christopher Brook3.   

Abstract

Within otolaryngology, scribes have been utilized as a means of increasing clinic efficiency and easing workload on physicians. During the COVID-19 pandemic, a majority of otolaryngology clinic appointments at academic institutions have been moved to telemedicine in order to limit interpersonal contacts. At the height of the pandemic, our institution has protocolized scribe participation from in-person to remote. Scribes have virtually participated in telemedicine appointments in an effort to facilitate documentation and enhance the patient-physician relationship. Beyond the pandemic, as patients start being evaluated in-person, the risk of contamination and spread through aerosol generating procedures has limited the number of ancillary support staff that can be present in the examination rooms. As such, virtual scribing from a separate location within the clinic has been deemed warranted. This paper documents the protocols on virtual scribing for both telemedicine and a hybrid approach for in-clinic appointments where high-risk procedures are being performed.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Clinic; Otolaryngology; Scribe; Telehealth; Virtual

Mesh:

Year:  2020        PMID: 32580066      PMCID: PMC7301782          DOI: 10.1016/j.amjoto.2020.102611

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


Discussion

The effects of the COVID-19 pandemic on the field of otolaryngology have been substantial, affecting all areas of patient care including ancillary support. Prior to the pandemic, in 2014, there were approximately 10,000 scribes nationwide represented in all surgical and medical fields [1]. These numbers speak to the usefulness of scribes in a clinical setting. In a study done in a safety net hospital in Minnesota, scribes were implemented throughout the institution and scribe support was well received in multiple clinical settings. Benefits for providers were seen in documentation time and ability to listen to patients [2]. At our institution within the field of otolaryngology, scribes have been used for years, and have been demonstrated to improve the clinic workflow without impairing patient satisfaction [3]. However, during the COVID-19 pandemic clinical volume has decreased dramatically, and practicing otolaryngologists have embraced alternative virtual methods to continue providing for their patients. There has been a shift in clinical practice into telemedicine whenever possible, and thus in-person scribe involvement, and the benefits they provide, in many clinical scenarios has ceased [4]. In our institution, a method of incorporating virtual scribe participation into outpatient telemedicine clinics was implemented. Through trial and error, we created an effective protocol to allow for scribe participation in telehealth allowing otolaryngologists more time focused on conversing with patients, all while enhancing efficiency. This protocol for scribe participation in telemedicine appointments is described in Fig. 1 .
Fig. 1

Virtual scribing during otolaryngology telemedicine appointments. A Scribe's perspective.

Virtual scribing during otolaryngology telemedicine appointments. A Scribe's perspective. However, at the time of this writing as the number of COVID-19 cases decrease, there has been a ramp-up in in-person clinic appointments which poses certain challenges. Multiple studies have been published evaluating the risks of generating contaminating aerosols by manipulating sinonasal mucosa in the setting of the COVID-19 [5,6]. As such, it is in the best interest of otolaryngologists to reduce the number of professionals, including scribes, in the room during aerosol generating procedures. In order to continue to benefit from the efforts of scribes in the otolaryngology clinic during the pandemic, we have devised a protocol for virtual scribing, in which the scribe is in a separate location of clinic for the appointments that would involve aerosol generating procedures. This protocol is described in Fig. 2 . We suggest this hybrid approach of virtual scribing, in which scribes are present in a different area of clinic, and scribe remotely for these types of appointments. During all other non-aerosol-generating patient interactions, the scribe can attend in-person.
Fig. 2

Virtual scribing during otolaryngology in-person clinic appointments involving aerosol-generating procedures.

Virtual scribing during otolaryngology in-person clinic appointments involving aerosol-generating procedures. Scribes have been involved in clinical activities within the field of otolaryngology for a number of years at our institution. At the height of the COVID-19 pandemic, because of these protocols, scribes have been able to provide valuable services to our clinics remotely, assisting in providing effective clinical care for practicing otolaryngologists during telemedicine appointments. However more recently, as the clinical ramp-up continues, the number of classical in-person clinic appointments will start to rise. Given the risks of aerosol-generating procedures, otolaryngologist and scribes have found the hybrid approach to virtual scribing an effective experience for safe patient care while continuing to improve clinic efficiency. While prior studies have supported the value of virtual scribing, this is the first publication providing logistical details on how to implement virtual scribing in the field of otolaryngology [7]. With these guidelines and recommendations, scribes within otolaryngology can continue to engage with practicing otolaryngologists in various clinical scenarios and provide documentation support in a safe and effective manner.

Conclusion

Scribes have had a positive impact in the field of medicine and otolaryngology by improving clinic efficiency and enhancing physician patient relationships. However, during the COVID-19 Pandemic, many otolaryngology clinics turned to virtual methods to continue seeing their patients. Beyond the COVID-19 pandemic, the risk of aerosol generating procedures will undoubtedly limit the presence of ancillary staff in the examination rooms for the near future. Here we present protocols for scribes to engage with otolaryngologists via telehealth, as well as virtually during in-clinic appointments when high-risk procedures are being performed.

Funding disclosures

None.

Author contributions

Renee Noordzij: Conceptualization, Methodology, Roles/Writing - original draft; Writing - review & editing. Michal J. Plocienniczak M.D. M.S.: Roles/Writing - original draft; Writing - review & editing Christopher Brook, M.D.: Roles/Writing - original draft; Writing - review & editing.

Declaration of competing interest

All authors declare they have no financial, consultant, institutional, or other relationships that may lead to a bias or conflict of interest.
  4 in total

Review 1.  The Use of Medical Scribes in Primary Care Settings: A Literature Synthesis.

Authors:  Margaret Ziemann; Clese Erikson; Maddie Krips
Journal:  Med Care       Date:  2021-10-01       Impact factor: 3.178

2.  Medical Scribe Impact on Provider Efficiency in Outpatient Radiation Oncology Clinics Before and During the COVID-19 Pandemic.

Authors:  Max Devine; Elyn Wang; Rie von Eyben; Hilary P Bagshaw
Journal:  Telemed Rep       Date:  2022-01-07

Review 3.  Digital scribe utility and barriers to implementation in clinical practice: a scoping review.

Authors:  Shilpa Ghatnekar; Adam Faletsky; Vinod E Nambudiri
Journal:  Health Technol (Berl)       Date:  2021-06-02

4.  The future of medical scribes documenting in the electronic health record: results of an expert consensus conference.

Authors:  Sky Corby; Keaton Whittaker; Joan S Ash; Vishnu Mohan; James Becton; Nicholas Solberg; Robby Bergstrom; Benjamin Orwoll; Christopher Hoekstra; Jeffrey A Gold
Journal:  BMC Med Inform Decis Mak       Date:  2021-06-29       Impact factor: 2.796

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.